Tenofovir and Severe Symptomatic Hypophosphatemia
Tenofovir is a broadly used drug used for the treatment of human immunodeficiency virus (HIV). Although the initial results of the clinical trials supported the renal safety of Tenofovir, clinical use of it has caused a low, albeit a significant, risk of renal damage either in the form of AKI or CKD...
Main Authors: | Asim Kichloo MD, Savneek Singh Chugh MD, Sanjeev Gupta MD, Jay Panday MD, Ghazaleh Goldar MD Cand |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-05-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/2324709619848796 |
Similar Items
-
Atypical Hemolytic Uremic Syndrome Presenting as Acute Heart Failure—A Rare Presentation: Diagnosis Supported by Skin Biopsy
by: Asim Kichloo MD, et al.
Published: (2019-04-01) -
Multiple Myeloma as the Underlying Cause of Thrombotic Microangiopathy Leading to Acute Kidney Injury: Revisiting a Very Rare Entity
by: Savneek Chugh MD, et al.
Published: (2017-09-01) -
Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
by: Wendy Fang, et al.
Published: (2019-10-01) -
Long-Term Hypoparathyroidism and Hypophosphatemia in Dialysis Patients
by: Linda Shavit MD, et al.
Published: (2014-06-01) -
Hereditary X-Linked Hypophosphatemia and Thoracic Myelopathy
by: George Forrest, MD, et al.
Published: (2016-01-01)